rs4251545
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016123.4(IRAK4):c.1282G>A(p.Ala428Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,612,510 control chromosomes in the GnomAD database, including 10,368 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_016123.4 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 67Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_016123.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IRAK4 | NM_016123.4 | MANE Select | c.1282G>A | p.Ala428Thr | missense | Exon 11 of 12 | NP_057207.2 | ||
| IRAK4 | NM_001114182.3 | c.1282G>A | p.Ala428Thr | missense | Exon 12 of 13 | NP_001107654.1 | |||
| IRAK4 | NM_001351345.2 | c.1282G>A | p.Ala428Thr | missense | Exon 12 of 13 | NP_001338274.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IRAK4 | ENST00000613694.5 | TSL:1 MANE Select | c.1282G>A | p.Ala428Thr | missense | Exon 11 of 12 | ENSP00000479889.3 | ||
| IRAK4 | ENST00000551736.5 | TSL:1 | c.1282G>A | p.Ala428Thr | missense | Exon 12 of 13 | ENSP00000446490.1 | ||
| IRAK4 | ENST00000547101.5 | TSL:1 | n.*1184G>A | non_coding_transcript_exon | Exon 12 of 13 | ENSP00000449317.1 |
Frequencies
GnomAD3 genomes AF: 0.147 AC: 22324AN: 151884Hom.: 2164 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.114 AC: 28505AN: 250834 AF XY: 0.109 show subpopulations
GnomAD4 exome AF: 0.0996 AC: 145462AN: 1460508Hom.: 8191 Cov.: 31 AF XY: 0.0990 AC XY: 71950AN XY: 726566 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.147 AC: 22362AN: 152002Hom.: 2177 Cov.: 32 AF XY: 0.144 AC XY: 10706AN XY: 74300 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1 paper claims increased risk of gram positive infection
This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported.
Immunodeficiency 67 Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
not provided Benign:2
This variant is associated with the following publications: (PMID: 21576904)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at